Cerebral Venous Sinus Thrombosis: Re-exploration of Clinical Assessment Scales
Overview
This is a single-center, retrospective, open-label study. This study is planned to investigate the accuracy of mRS and NIHSS, comparing with the accuracy of CSF pressure and papilledema grade in assessing cerebral venous sinus thrombosis.
Full Title of Study: “Cerebral Venous Sinus Thrombosis: Re-exploration of Clinical Assessment”
Study Type
- Study Type: Observational
- Study Design
- Time Perspective: Retrospective
- Study Primary Completion Date: April 1, 2018
Clinical Trial Outcome Measures
Primary Measures
- baseline CSF pressure
- Time Frame: baseline
- CSF pressure at baseline
- baseline mRS
- Time Frame: baseline
- mRS at baseline
- baseline papilledema grade
- Time Frame: baseline
- Frisen grade of papilledema at baseline
Secondary Measures
- baseline NIHSS
- Time Frame: baseline
- NIH Stroke Scale at baseline
Participating in This Clinical Trial
Inclusion Criteria
- confirmed diagnosis of CVST by head MRI, DSA or MRV onset of CVST within one month Exclusion Criteria:
- unable to complete examinations unable to complete follow-ups
Gender Eligibility: All
Minimum Age: N/A
Maximum Age: N/A
Investigator Details
- Lead Sponsor
- Capital Medical University
- Provider of Information About this Clinical Study
- Principal Investigator: Ji Xunming, Professor – Capital Medical University
- Overall Contact(s)
- Xunming Ji, +86-83198952, jixunming@vip.163.com
Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.